Given irisin’s broad functionality in treating cognitive impairment-related diseases, pharmacologically increasing brain irisin levels may represent a new therapeutic strategy to prevent age-related cognitive decline, AD and DACD. Here, FNDC5 is linked to Alzheimer disease.